Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C21H21N3S |
Molecular Weight | 347.477 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CC3=CNC4=C3C(=CC=C4)C1=C[C@@H](CSC5=CC=CC=N5)CN2C
InChI
InChIKey=VCRAKEDGLIINLR-AUUYWEPGSA-N
InChI=1S/C21H21N3S/c1-24-12-14(13-25-20-7-2-3-8-22-20)9-17-16-5-4-6-18-21(16)15(11-23-18)10-19(17)24/h2-9,11,14,19,23H,10,12-13H2,1H3/t14-,19-/m1/s1
Molecular Formula | C21H21N3S |
Molecular Weight | 347.477 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Tiomergine is an ergot alkaloid derivative. It is the agonist of the postulated presynaptic dopamine receptor. Tiomergine is the antiparkinsonian agent. Tiomergine modified brain glucose metabolism in a way similar to the neuroleptics but different from postsynaptic agonists. It was ineffective in the treatment of tardive dyskinesia.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Treatment of dyskinetic and dystonic disorders with CF 25-397: clinical and pharmacological aspects. | 1980 |
|
Bromocriptine and CF 25-397 in the treatment of tardive dyskinesia. | 1980 Apr |
|
Presynaptic dopaminergic agonists modify brain glucose metabolism in a way similar to the neuroleptics. | 1984 Sep 7 |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:20:24 GMT 2023
by
admin
on
Fri Dec 15 15:20:24 GMT 2023
|
Record UNII |
85J22V47HN
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C66884
Created by
admin on Fri Dec 15 15:20:24 GMT 2023 , Edited by admin on Fri Dec 15 15:20:24 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000077231
Created by
admin on Fri Dec 15 15:20:24 GMT 2023 , Edited by admin on Fri Dec 15 15:20:24 GMT 2023
|
PRIMARY | |||
|
DTXSID901024153
Created by
admin on Fri Dec 15 15:20:24 GMT 2023 , Edited by admin on Fri Dec 15 15:20:24 GMT 2023
|
PRIMARY | |||
|
CHEMBL2104731
Created by
admin on Fri Dec 15 15:20:24 GMT 2023 , Edited by admin on Fri Dec 15 15:20:24 GMT 2023
|
PRIMARY | |||
|
C152639
Created by
admin on Fri Dec 15 15:20:24 GMT 2023 , Edited by admin on Fri Dec 15 15:20:24 GMT 2023
|
PRIMARY | |||
|
4640
Created by
admin on Fri Dec 15 15:20:24 GMT 2023 , Edited by admin on Fri Dec 15 15:20:24 GMT 2023
|
PRIMARY | |||
|
SUB11085MIG
Created by
admin on Fri Dec 15 15:20:24 GMT 2023 , Edited by admin on Fri Dec 15 15:20:24 GMT 2023
|
PRIMARY | |||
|
57935-49-6
Created by
admin on Fri Dec 15 15:20:24 GMT 2023 , Edited by admin on Fri Dec 15 15:20:24 GMT 2023
|
PRIMARY | |||
|
85J22V47HN
Created by
admin on Fri Dec 15 15:20:24 GMT 2023 , Edited by admin on Fri Dec 15 15:20:24 GMT 2023
|
PRIMARY | |||
|
9884658
Created by
admin on Fri Dec 15 15:20:24 GMT 2023 , Edited by admin on Fri Dec 15 15:20:24 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |